Advertisement
Monday, Nov 29, 2021
Outlook.com
Interview

‘India Will Need Hundreds Of Millions Of Doses’

Adar Poonawalla, CEO of Serum Institute, says he’s expecting the Indian trials of the Oxford vaccine to be over in January 2021.

‘India Will Need Hundreds Of Millions Of Doses’
‘India Will Need Hundreds Of Millions Of Doses’
outlookindia.com
2020-11-28T09:34:27+05:30

As the world’s largest vaccine manufacturer by volume of doses produced, the Pune-based Serum Institute of India is among the keenly-watched companies in the race for a COVID-19 vaccine. It is partnering with the Oxford University-AstraZeneca vaccine project, apart from two other candidates, in initial trials. Adar Poonawalla, CEO of Serum Institute, tells Ajay Sukumaran via email that he’s expecting the Indian trials of the Oxford vaccine to be over in January 2021. Edited excerpts:

How close is Oxford-Astra­Zeneca to delivering its COVID-19 vaccine under an emergency licence in the UK? How soon do you hope to get efficacy and safety data from your trials in India?

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Maharashtra CM Uddhav Thackeray has instructed all the ministers in charge of the districts to tighten coordination with the local administration to ensure proper prevention of another Covid-19 outbreak.

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Shreyas Iyer hit 105 and 65 against New Zealand to become the first Indian batter to score a century and half-century in his debut Test match.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

Advertisement